ESG Telegraph
  • Home
  • Latest News
  • Environment
  • Companies
  • Investors
  • Governance
  • Markets
  • Social
  • Regulators
  • Sustainable Finance
Featured Posts
    • Companies
    European office market faces biggest test since financial crisis
    • August 15, 2022
    • Markets
    Uniper drops coal case as tensions rise over treaty on fossil fuel projects
    • August 15, 2022
    • Latest News
    Stock markets subdued after weaker than expected Chinese data
    • August 15, 2022
    • Companies
    Vanguard active funds suffer bloodiest first-half on record
    • August 15, 2022
    • Markets
    Why the Fed might be at ‘neutral’ already on monetary policy
    • August 15, 2022
Featured Categories
Belarussia
View Posts
Companies
View Posts
Energy
View Posts
Environment
View Posts
Food
View Posts
Governance
View Posts
Health
View Posts
Investors
View Posts
Latest News
View Posts
Markets
View Posts
Potash
View Posts
Regulators
View Posts
Russsia
View Posts
Social
View Posts
Supply Chain
View Posts
Sustainable Finance
View Posts
Technology
View Posts
Uncategorized
View Posts
ESG Telegraph ESG Telegraph
7K
9K
4K
1K
ESG Telegraph ESG Telegraph
  • Home
  • Latest News
  • Environment
  • Companies
  • Investors
  • Governance
  • Markets
  • Social
  • Regulators
  • Sustainable Finance
  • Companies

GSK: £50bn-plus takeover would leave Unilever omnileveraged

  • January 15, 2022
  • Staff
Total
0
Shares
0
0
0

At first blush, it looks like just a little bit of an overreaction. Investor Terry Smith mocked socially-conscious Unilever for defining the “purpose” of Hellmann’s mayonnaise amid disappointing share price performance. A few days later, the UK-listed consumer products group confirmed that it had made a £50bn approach for a rival business belonging to GSK.

Unilever would probably have to go higher to win, shouldering heavy debts. Shareholders who feared the company lacked ambition may now worry it has too much fire in its belly.

Unilever was, of course, plotting an approach for GSK’s consumer products division long before Smith’s comments became public. The pharmaceuticals group, under pressure from its own shareholders, has been planning to demerge the unit via a separate listing. Last month it appointed ex-Tesco boss Dave Lewis to chair the business.

The bidder, which owns brands such as Marmite and Domestos, has a good chance of derailing the demerger. Pfizer owns 32 per cent of GSK consumer products. The US drugs group has triumphed as a vaccine producer. It is hardly pinning its hopes on the GSK business that owns Aquafresh toothpaste. Activist investor Elliott would likely prefer cash to promises too.

The sticking point will be the amount Unilever and its own investors are willing to stump up. Its latest £50bn approach was around four-fifths in cash with the balance in shares. Lex values the consumer division at £43bn-£45bn, assuming a multiple of some 16 times forward ebitda typical in this sector.

The snag is that the £5-7bn control premium offered by Unilever on top of that looks slim. GSK — which published upgraded sales growth figures — is right to complain of undervaluation.

An uplift of at least 25 per cent is considered normal in the laggardly UK market. That would be some £11bn at the top end, taking Unilever to a total price of £55bn for the GSK unit. Cost savings and other benefits might be conservatively worth about £8bn, taxed and capitalised.

The enlarged Unilever could cover up to £35bn of an increased price with medium-term debt. But that would double its leverage to some four times net debt to ebitda, steep for a FTSE-100 company. To get to £55bn it might need to take on additional short-term borrowing, repayable with proceeds from disposals. Unilever might also have to offer more equity.

Unilever chief executive Alan Jope would be betting big that he could squeeze higher profits from GSK’s consumer brands. This would depend on his success in taking them into developing markets, where his own company is better represented.

In contrast, wringing top dollar from Unilever would lift much of the weight from the shoulders of GSK boss Emma Walmsley. Critics have questioned her pharmaceutical expertise. There is no doubt she is a canny deal maker. She should seize this opportunity.

The Lex team is interested in hearing more from readers. Please tell us what you think of Unilever’s audacious approach for GSK consumer products in the comments section below.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
You May Also Like
Read More
  • Companies

European office market faces biggest test since financial crisis

  • Staff
  • August 15, 2022
Read More
  • Companies

Vanguard active funds suffer bloodiest first-half on record

  • Staff
  • August 15, 2022
Read More
  • Companies

Digital advertising: Apple takes bigger bite of new business

  • Staff
  • August 15, 2022
Read More
  • Companies

Climate and crypto fraught with challenges for regulators 

  • Staff
  • August 15, 2022
Read More
  • Companies

FirstFT: European office market’s big test

  • Staff
  • August 15, 2022
Read More
  • Companies

How female founders are challenging the funding gap

  • Staff
  • August 15, 2022
Read More
  • Companies

UK employers could be forced to pay down pension deficits

  • Staff
  • August 15, 2022
Read More
  • Companies

Afghan roads once menaced by the Taliban are now safer. . . for some

  • Staff
  • August 15, 2022

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Featured Posts
  • 1
    European office market faces biggest test since financial crisis
    • August 15, 2022
  • 2
    Uniper drops coal case as tensions rise over treaty on fossil fuel projects
    • August 15, 2022
  • 3
    Stock markets subdued after weaker than expected Chinese data
    • August 15, 2022
  • 4
    Vanguard active funds suffer bloodiest first-half on record
    • August 15, 2022
  • 5
    Why the Fed might be at ‘neutral’ already on monetary policy
    • August 15, 2022
Recent Posts
  • Rio Tinto rebuffed in plan to take control of Mongolia copper project
    • August 15, 2022
  • Digital advertising: Apple takes bigger bite of new business
    • August 15, 2022
  • At 75, India is finally ready to join the global party
    • August 15, 2022

Sign Up for Our Newsletters

Subscribe now to our newsletter

ESG Telegraph
  • Home
  • Privacy Policy
  • Guest Post
  • Contact

Input your search keywords and press Enter.